Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Bio Rad Laboratories Inc BIO

Alternate Symbol(s):  BIO.B

Technology Scientific & Technical Instruments
Bio-Rad Laboratories, Inc. is engaged in developing, manufacturing, and marketing a range of products for the life science research and clinical diagnostics markets. The Company offers a range of products and systems used to separate complex chemical and biological materials and to identify, analyze and purify their components. The Company operates through two segments: Life Science and... see more

Recent & Breaking News (NYSE:BIO)

Relmada Therapeutics Announces Participation in Jefferies Virtual Healthcare Conference

PR Newswire June 1, 2021

Century Therapeutics Adds Respected Biotech Executives to Board of Directors

PR Newswire June 1, 2021

Rapid Discharge with Minimal PACU Opioids was Key Message During Presentation of DSUVIA® For Analgesia in Plastic Surgery Procedures at the California Society of Plastic Surgeons Annual Meeting

PR Newswire June 1, 2021

Hoth Therapeutics Plans Shareholder Presentation on HT-KIT Therapeutic's Preclinical Results for Rare Cancers

PR Newswire June 1, 2021

SOPHiA GENETICS Advances Blood Cancer Genomic Testing With New Myeloid Solutions

PR Newswire June 1, 2021

Avails Medical's eQUANT(TM) paper 'Novel electronic biosensor for automated inoculum preparation to accelerate antimicrobial susceptibility testing' published in Scientific Reports

PR Newswire June 1, 2021

Viracta Therapeutics Announces the Initiation of NAVAL-1, a Global Pivotal Trial for the Treatment of Relapsed/Refractory Epstein-Barr Virus-Positive Lymphoma

PR Newswire June 1, 2021

Curis, Inc. Announces 2021 Virtual Symposium: "VISTA: A New Immune Checkpoint in Cancer, Autoimmunity and Beyond"

PR Newswire June 1, 2021

ViaCyte to Present Late-Breaking Data at the American Diabetes Association's 81st Scientific Sessions

PR Newswire June 1, 2021

BioVaxys And Bioproduction Partner Bio Elpida Begin Construction Of GMP Facility To Produce Clinical Supply For Planned Ovarian Cancer Vaccine Study

Canada NewsWire June 1, 2021

Neurophth Therapeutics and Hopstem Biotechnology Announce Strategic Partnership to Develop Human Induced Pluripotent Stem Cell-Derived Therapies for the Treatment of Ocular Diseases

PR Newswire June 1, 2021

Kontrol to provide BioCloud Viral Detection and Insight Model to Commercial Real Estate Management Company

Canada NewsWire June 1, 2021

Think Research Joins PointClickCare Technologies Marketplace to Offer Best in Class API Technology Integration with Leading Healthcare Platform Provider

Canada NewsWire June 1, 2021

Mirati Therapeutics and Zai Lab Enter Into a Collaboration to Develop and Commercialize Adagrasib in Greater China

PR Newswire June 1, 2021

PsyBio Therapeutics Reports First Quarter 2021 Financial Results, Provides Shareholder Update and Announces Intention to Institute Share Buyback Program

Canada NewsWire June 1, 2021

Provention Bio to Present at the Jefferies Virtual Healthcare Conference

PR Newswire June 1, 2021

Endpoints News presents its annual (and once again virtual) R&D Summit: June 14-16

PR Newswire June 1, 2021

CTI BioPharma Announces Acceptance of NDA Granted with Priority Review of Pacritinib for Treatment of Patients with Myelofibrosis

PR Newswire June 1, 2021

Small Pharma Inc. Expands Phase I/IIa Clinical Trial With Additional Study Site

PR Newswire June 1, 2021

Sutro Biopharma Earns Milestone Payment from Bispecific Antibody-Drug Conjugate Collaboration with Merck KGaA, Darmstadt, Germany

PR Newswire June 1, 2021